CDH2 and cancer: IL-6 has also been shown to promote epithelial–mesenchymal transition (EMT) in several cancers through the altered expression of E- and N-cadherin [111,115,116], Vimentin [117], Snail [109,116,118], Twist [119,120], and others [109].